Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling.

Plasma membrane subdomain compartmentalization contributes to distinct mechanisms of ceramide action on insulin signaling.
复制标题

DOI:
10.2337/db09-0897
复制
发表时间:
2010-03
期刊:
影响因子:
7.7
通讯作者:
Hajduch E
Hajduch E
中科院分区:
医学1区
文献类型:
--
作者:
Blouin CM;Prado C;Takane KK;Lasnier F;Garcia-Ocana A;Ferré P;Dugail I;Hajduch E

文献摘要

参考文献

被引文献

相似文献

神经酰胺现在被认为是胰岛素信号的负调节因子,通过损害蛋白激酶B (PKB)/Akt的激活。在不同的细胞中,已经提出了两种不同的机制来介导神经酰胺对PKB/Akt的抑制:一种涉及非典型蛋白激酶Cζ (PKCζ),另一种涉及蛋白磷酸酶-2 (PP2A)。我们假设神经酰胺通过PKCζ或PP2A的作用可能取决于质膜(PM)的结构组织,特别是小泡蛋白富集域(CEM)的丰度。我们使用了不同的PKCζ突变体结构或PP2A抑制剂冈田酸(OKA),在表达不同小窝蛋白-1水平的细胞中选择性地抑制PKCζ和PP2A依赖通路,并评估了胰岛素和神经酰胺对不同PM亚结构域PKB/Akt活性的影响。尽管神经酰胺对胰岛素刺激的PKB/Akt的负面影响在脂肪细胞中占主导地位,但神经酰胺通过CEMs外的PP2A作用,被OKA阻止,也被揭示。为了测试CEM通过PKCζ通路直接神经酰胺作用的重要性,我们用神经酰胺处理缺乏CEM的3T3-L1前脂肪细胞,我们发现PKB/Akt的脂质阴性作用转变为pp2a介导的机制。在CEM丰度较低的成纤维细胞中,神经酰胺激活的PP2A途径占主导地位,但在caveolin-1过表达后,可以转移到神经酰胺激活的PKCζ途径。我们的研究结果表明,神经酰胺可以从pkc - ζ依赖机制转变为PP2A途径,对PKB/Akt起负作用,从而揭示了PM的CEMs在这一过程中的关键作用。
Ceramide is now recognized as a negative regulator of insulin signaling by impairing protein kinase B (PKB)/Akt activation. In different cells, two distinct mechanisms have been proposed to mediate ceramide inhibition of PKB/Akt: one involving atypical protein kinase C zeta (PKCζ) and the other the protein phosphatase-2 (PP2A). We hypothesized that ceramide action through PKCζ or PP2A might depend on plasma membrane (PM) structural organization and especially on caveolin-enriched domain (CEM) abundance. We have used different PKCζ mutant constructs or the PP2A inhibitor, okadaic acid (OKA), to selectively inhibit PKCζ- and PP2A-dependent pathways in cells expressing different caveolin-1 levels and evaluated the impact of insulin and ceramide on PKB/Akt activity in different PM subdomains. Although the PKCζ-mediated negative effect of ceramide on insulin-stimulated PKB/Akt was dominant in adipocytes, a ceramide action through PP2A outside CEMs, prevented by OKA, was also unraveled. To test the importance of CEM to direct ceramide action through the PKCζ pathway, we treated 3T3-L1 preadipocytes devoid of CEMs with ceramide and we saw a shift of the lipid-negative action on PKB/Akt to a PP2A-mediated mechanism. In fibroblasts with low CEM abundance, the ceramide-activated PP2A pathway dominated, but could be shifted to a ceramide-activated PKCζ pathway after caveolin-1 overexpression. Our results show that ceramide can switch from a PKCζ-dependent mechanism to a PP2A pathway, acting negatively on PKB/Akt, and hence revealing a critical role of CEMs of the PM in this process.
DOI: 10.1073/pnas.92.19.8655
发表时间: 1995-09-12
影响因子: 11.1
作者:
FRA, AM;WILLIAMSON, E;PARTON, RG
通讯作者: PARTON, RG
DOI: 10.1038/emm.2005.23
发表时间: 2005-06-30
影响因子: 12.8
作者:
Ha, H;Pak, Y
通讯作者: Pak, Y
DOI: 10.1016/0026-2862(90)90055-v
发表时间: 1990-01-01
影响因子: 3.1
作者:
GUILLOT, FL;AUDUS, KL;RAUB, TJ
通讯作者: RAUB, TJ
DOI: 10.1083/jcb.129.4.999
发表时间: 1995-05-01
影响因子: 7.8
作者:
KANDROR, KV;STEPHENS, JM;PILCH, PF
通讯作者: PILCH, PF
DOI: 10.1074/jbc.m007346200
发表时间: 2000-11-10
影响因子: 4.8
作者:
Bourbon, NA;Yun, J;Kester, M
通讯作者: Kester, M